M 14 Pill - orange round, 6mm
Pill with imprint M 14 is Orange, Round and has been identified as Methotrexate Sodium 2.5 mg. It is supplied by Mylan Pharmaceuticals Inc.
Methotrexate is used in the treatment of Acute Lymphoblastic Leukemia; Acute Lymphocytic Leukemia; Breast Cancer; Systemic Sclerosis; Solid Tumors and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 14
Methotrexate Sodium
- Imprint
- M 14
- Strength
- 2.5 mg
- Color
- Orange
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antimetabolites, Antipsoriatics, Antirheumatics, Other immunosuppressants
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
corn starch,
sodium carbonate monohydrate,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
FD&C Red No. 40
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-0014 | Mylan Pharmaceuticals Inc. |
| 51079-0670 | UDL Laboratories Inc. |
Related images for "M 14"
More about methotrexate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (330)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: antimetabolites
- Breastfeeding
Patient resources
- Methotrexate drug information
- Methotrexate injection
- Methotrexate (Injection, Subcutaneous) (Advanced Reading)
- Methotrexate (Oral) (Advanced Reading)
- Methotrexate Injection (Subcutaneous)
Other brands
Otrexup, Trexall, Rasuvo, Rheumatrex Dose Pack, ... +3 more
Professional resources
Other brands
Otrexup, Trexall, Rasuvo, Rheumatrex Dose Pack, ... +3 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
